Shukra Pharmaceuticals (BOM:524632) Other Operating Expense : ₹127.3 Mil (TTM As of Mar. 2024)

View and export this data going back to 2000. Start your Free Trial

What is Shukra Pharmaceuticals Other Operating Expense?

Shukra Pharmaceuticals's Other Operating Expense for the three months ended in Mar. 2024 was ₹53.4 Mil. Its Other Operating Expense for the trailing twelve months (TTM) ended in Mar. 2024 was ₹127.3 Mil.

Shukra Pharmaceuticals's quarterly Other Operating Expense increased from Sep. 2023 (₹24.3 Mil) to Dec. 2023 (₹25.8 Mil) and increased from Dec. 2023 (₹25.8 Mil) to Mar. 2024 (₹53.4 Mil).

Shukra Pharmaceuticals's annual Other Operating Expense increased from Mar. 2022 (₹83.8 Mil) to Mar. 2023 (₹92.6 Mil) and increased from Mar. 2023 (₹92.6 Mil) to Mar. 2024 (₹127.3 Mil).

Shukra Pharmaceuticals Other Operating Expense Historical Data

The historical data trend for Shukra Pharmaceuticals's Other Operating Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Shukra Pharmaceuticals Other Operating Expense Chart

Shukra Pharmaceuticals Annual Data

Trend

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

Other Operating Expense

Get a 7-Day Free Trial

84.97

79.07

83.83

92.62

127.33

Shukra Pharmaceuticals Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Other Operating Expense	Get a 7-Day Free Trial															35.69	23.72	24.34	25.83	53.43

Shukra Pharmaceuticals Other Operating Expense Calculation

GuruFocus uses a standardized financial statement format for all companies. For non-financial companies, GuruFocus lists Selling, General, & Admin. Expense, , Research & Development, and Other Operating Expense under the "Total Operating Expense" section.

Other Operating Expense sometimes includes:
Restructuring, and merger
Acquisition related and other
Litigation settlement charge
Other (too numerous to list)

Some companies can and do choose to report each of these items separately. Yet, there are a variety of Other Operating Expense which are simply too numerous to list.

Other Operating Expense for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹127.3 Mil.

Shukra Pharmaceuticals Other Operating Expense Related Terms

Thank you for viewing the detailed overview of Shukra Pharmaceuticals's Other Operating Expense provided by GuruFocus.com. Please click on the following links to see related term pages.

Shukra Pharmaceuticals (BOM:524632) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Shukra Pharmaceuticals Ltd (BOM:524632) » Definitions » Other Operating Expense

Traded in Other Exchanges

N/A

Address

Judges Bunglow Road, Bodakdev, 3rd Floor, Veer House, Opposite WIAA Office, Ahmedabad, GJ, IND, 380054

Website

https://www.shukrapharmaceuticals.com

Shukra Pharmaceuticals Ltd is engaged in the business of manufacturing and trading pharmaceutical products. The company markets its products in India and international markets. The company has two operating segments; pharmaceutical and Laboratory. Its product portfolio includes antibiotics, antibiotics, quinolones, macrolides, anti-bacterial, anti-fungal, anti-malarial, anti-viral, antiprotozoal, anti-anthelmintic, anti-depressant, anti-manic, anti-emetic, beta-blockers, analgesic, muscle relaxants, anti-tuberculosis, vitamin products, anti-allergic, corticosteroids, hyper and hypoglycemic, and others. It exports its products to Australia, Uganda, Kenya, the United Kingdom, Sri Lanka, Mauritius, and the Republic of Yemen.

Shukra Pharmaceuticals (BOM:524632) Headlines

No Headlines